The global microplate systems market accounted for USD 1.14 billion in 2023 and is expected to reach at USD 3.60 billion by 2034 with a CAGR of 11.02% during the forecast period 2024-2034. The market will grow due to factors such as the increasing prevalence of chronic diseases, improvements in drug discovery and development, a rise in research and development activities, a rise in the demand for clinical diagnostics, an expansion of applications in food and environmental testing, and an emphasis on personalized medicine.
Microplate systems are widely used in clinical diagnostics to identify infectious pathogens, disease-associated genetic variants, and biomarkers. The deployment of microplate systems in clinical laboratories and diagnostic centers is boosted by the rising prevalence of diseases and the growing demand for precise and effective diagnostic instruments. For instance, Thermo Fisher Scientific Inc. announced the release of the "SpectraMax iD5 Multi-Mode Microplate Reader" in February 2024, which offers improved sensitivity and a larger dynamic range for a variety of tests.
By microplate reader, the single-mode microplate readers segment accounted for the highest revenue-grossing segment in the global microplate systems market in 2023 owing to the increasing demand for specialized and cost-effective solutions for targeted applications. For instance, PerkinElmer, Inc. introduced the "EnVision Multimode Plate Reader" in October 2023, emphasizing more efficient workflows and enhanced data processing capabilities. Additionally, the multi-mode microplate readers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for versatile and multifunctional instruments in various research and diagnostic applications.
By application, the clinical diagnostics segment accounted for the highest revenue-grossing segment in the global microplate systems market in 2023 owing to the rising prevalence of chronic diseases and the increasing need for accurate and efficient diagnostic tools. For instance, Danaher Corporation Molecular Devices, a Danaher subsidiary, debuted the "Select Dispenser S1" in August 2023. This automated liquid handling system is intended for use in high-throughput screening scenarios. Additionally, the drug discovery segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investment in R&D and the need for high-throughput screening technologies.
By end-user, the hospitals and diagnostic laboratories segment accounted for the highest revenue-grossing segment in the global microplate systems market in 2023 owing to the rising demand for advanced diagnostic testing and increasing patient volumes. For instance, Agilent Technologies, Inc. and Stevanato Group announced a partnership in March 2024 to create an integrated platform for on-body drug delivery, possibly with the use of microplate systems for pre-clinical testing. Additionally, the biotechnology and pharmaceutical company segment is predicted to grow at the fastest CAGR during the forecast period owing to the escalating investment in drug discovery and development.
North American region is anticipated to have the highest revenue share during the forecast period owing to the advanced healthcare infrastructure and significant investment in research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the expanding healthcare infrastructure and increasing investments in biotechnology and pharmaceutical research. For instance, Thermo Fisher announced in January 2024 that it had acquired Olink Holding AB, a leader in next-generation proteomics, to improve their capacity for the discovery and development of protein biomarkers.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Microplate systems are widely used in clinical diagnostics to identify infectious pathogens, disease-associated genetic variants, and biomarkers. The deployment of microplate systems in clinical laboratories and diagnostic centers is boosted by the rising prevalence of diseases and the growing demand for precise and effective diagnostic instruments. For instance, Thermo Fisher Scientific Inc. announced the release of the "SpectraMax iD5 Multi-Mode Microplate Reader" in February 2024, which offers improved sensitivity and a larger dynamic range for a variety of tests.
By microplate reader, the single-mode microplate readers segment accounted for the highest revenue-grossing segment in the global microplate systems market in 2023 owing to the increasing demand for specialized and cost-effective solutions for targeted applications. For instance, PerkinElmer, Inc. introduced the "EnVision Multimode Plate Reader" in October 2023, emphasizing more efficient workflows and enhanced data processing capabilities. Additionally, the multi-mode microplate readers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for versatile and multifunctional instruments in various research and diagnostic applications.
By application, the clinical diagnostics segment accounted for the highest revenue-grossing segment in the global microplate systems market in 2023 owing to the rising prevalence of chronic diseases and the increasing need for accurate and efficient diagnostic tools. For instance, Danaher Corporation Molecular Devices, a Danaher subsidiary, debuted the "Select Dispenser S1" in August 2023. This automated liquid handling system is intended for use in high-throughput screening scenarios. Additionally, the drug discovery segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investment in R&D and the need for high-throughput screening technologies.
By end-user, the hospitals and diagnostic laboratories segment accounted for the highest revenue-grossing segment in the global microplate systems market in 2023 owing to the rising demand for advanced diagnostic testing and increasing patient volumes. For instance, Agilent Technologies, Inc. and Stevanato Group announced a partnership in March 2024 to create an integrated platform for on-body drug delivery, possibly with the use of microplate systems for pre-clinical testing. Additionally, the biotechnology and pharmaceutical company segment is predicted to grow at the fastest CAGR during the forecast period owing to the escalating investment in drug discovery and development.
North American region is anticipated to have the highest revenue share during the forecast period owing to the advanced healthcare infrastructure and significant investment in research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the expanding healthcare infrastructure and increasing investments in biotechnology and pharmaceutical research. For instance, Thermo Fisher announced in January 2024 that it had acquired Olink Holding AB, a leader in next-generation proteomics, to improve their capacity for the discovery and development of protein biomarkers.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Microplate Reader, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Microplate Systems Market Report 2023 - 2034
Microplate Systems Market Analysis & Forecast by Microplate Reader 2023 - 2034 (Revenue USD Bn)
- Multi-mode Microplate Readers
- Filter-based Readers
- Hybrid Readers
- Single-mode Microplate Readers
- Monochromator-based Readers
- Fluorescence Plate Readers
- Absorbance Plate Readers
- Microplate pipetting systems and dispensers
- Microplate washers
- Luminescence Plate Readers
- Other Products
Microplate Systems Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Drug discovery
- Clinical diagnostics
- Genomics and Proteomics research
- Other applications
Microplate Systems Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Biotechnology and pharmaceutical companies
- Hospitals and diagnostic laboratories
- Research and academic institutes
Microplate Systems Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Microplate Systems Market: Microplate Reader Estimates & Trend Analysis
8. Microplate Systems Market: Application Estimates & Trend Analysis
9. Microplate Systems Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Microplate Systems Market
12. Europe Global Microplate Systems Market
13. Asia Pacific Global Microplate Systems Market
14. Latin America Global Microplate Systems Market
15. MEA Global Microplate Systems Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Danaher Corporation (Molecular Devices LLC)
- Agilent Technologies Inc.
- BMG LABTECH GmbH
- BioTek Instruments Inc. (part of Agilent Technologies)
- Tecan Group Ltd.
- Corning Incorporated
- Promega Corporation
- Bio-Rad Laboratories Inc.
- Berthold Technologies GmbH & Co. KG
- Enzo Life Sciences Inc.
- Lonza Group Ltd.
- Bruker Corporation
- Eppendorf AG.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | October 2024 |
Forecast Period | 2023 - 2034 |
Estimated Market Value ( USD | $ 1.14 Billion |
Forecasted Market Value ( USD | $ 3.6 Billion |
Compound Annual Growth Rate | 11.0% |
Regions Covered | Global |
No. of Companies Mentioned | 15 |